Zhu_2024_Pol.J.Pathol_75_97

Leukaemia-related protein 16 (LRP16) has been found to be highly expressed in various tumours and to be related to poor prognosis. However, the role of LRP16 in endometrial carcinoma remains to be explored. We aimed to investigate the prognosis and role of LRP16 in endometrial carcinoma. Overall, 160 endometrial carcinoma (EC) tissues and 60 benign samples were collected. The expression of LRP16 protein in EC tissues was significantly increased compared with that in normal endometrial tissues, and high LRP16 expression was related to poor patient prognosis. Reduced LRP16 expression markedly inhibited cancer cell growth. The proliferation rates in the prophylactic bilateral salpingectomy (PBS) group and the shNon group were 0.727 +/-0.015 and 0.743 +/-0.009, respectively, while the proliferation rate in the shLRP16 group was only 0.373 +/-0.012. The migration experiment showed that the number of cells passing through the basement membrane in the shLRP16 group was 34.2 +/-5.1, which was significantly different to the shNon (161.6 +/-7.8) and PBS groups (138.0 +/-7.2). The results of the invasion experiment showed that the number of cells was 39.2 +/-6.2 in the shLRP16 group, 146.7 +/-8.2 in the shNon group, and 141.2 +/-8.1 in the PBS group ( p < 0.05). Leukaemia-related protein 16 is highly expressed in oestrogen-dependent EC and may promote cancer cell growth.